Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France
Launched by UNIVERSITY HOSPITAL, LILLE · Apr 3, 2020
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1st Line Consultation in Pediatric Emergencies
- • All reasons for consultation during working hours
- • Informed and written consent of a parent holder (only 1 authorized companion) and a child of understanding age
- Exclusion Criteria:
- • Refusal of participation by parents/child of decision age
- • No membership of a social security scheme (beneficiary or entitled)
- • No understanding of French
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tours, , France
Nice, , France
Colombes, , France
Lille, , France
Nantes, , France
Toulouse, , France
Patients applied
Trial Officials
François Dubos, MD,PhD
Principal Investigator
University Hospital, Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials